Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy

Lignende værker

• Soluble PD-L1 (sPD-L1) as a biomarker of durable response and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with first-line immune checkpoint inhibitors (ICIs)
  af: Adrien Costantini, et al.
  Udgivet: (2025-08-01)
• Recent Advances in Immunotherapy in Metastatic NSCLC
  af: Bansal, Pranshu, et al.
  Udgivet: (2016)
• Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?
  af: Costantini, Adrien, et al.
  Udgivet: (2019)
• Editorial: Recent Advances in Diagnosis and Management of Urothelial Carcinoma
  af: Ku, Ja Hyeon, et al.
  Udgivet: (2021)
• Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC
  af: Bansal, Pranshu, et al.
  Udgivet: (2016)